Literature DB >> 10965274

Thalamic and hypothalamic tumors of childhood: endocrine late effects.

S E Oberfield1, J H Garvin.   

Abstract

Children who have received chemotherapy and radiation therapy for treatment of thalamic/hypothalamic tumors are at risk for late effects, specifically endocrine dysfunction. Evaluation of growth and pubertal development, thyroid function and integrity of the hypothalamic-pituitary-adrenal axis should be undertaken in a prospective manner. Issues of metabolic disturbances such as obesity, altered body composition/bone density as well as ultimate fertility also need to be addressed by ongoing prospective evaluations. Copyright 2000 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10965274     DOI: 10.1159/000028949

Source DB:  PubMed          Journal:  Pediatr Neurosurg        ISSN: 1016-2291            Impact factor:   1.162


  3 in total

1.  Thalamic tumors in children.

Authors:  Burcak Bilginer; Firat Narin; Ilkay Işıkay; Kader Karlı Oguz; Figen Söylemezoglu; Nejat Akalan
Journal:  Childs Nerv Syst       Date:  2014-04-22       Impact factor: 1.475

2.  Effectiveness of novel combination chemotherapy, consisting of 5-fluorouracil, vincristine, cyclophosphamide and etoposide, in the treatment of low-grade gliomas in children.

Authors:  Mee Jeong Lee; Young Shin Ra; Jun Bum Park; Hyun Woo Goo; Seung Do Ahn; Shin Kwang Khang; Joon Sup Song; Yoon Jung Kim; Thad T Ghim
Journal:  J Neurooncol       Date:  2006-06-29       Impact factor: 4.130

3.  Pituitary insufficiency after operation of supratentorial intra- and extraaxial tumors outside of the sellar-parasellar region?

Authors:  Dorothee Wachter; Nicole Gondermann; Matthias F Oertel; Ulf Nestler; Veit Rohde; Dieter-Karsten Böker
Journal:  Neurosurg Rev       Date:  2011-06-15       Impact factor: 3.042

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.